Multiple vector vaccine for hepatitis C virus.

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A successful vaccine for RNA viruses like HIV and hepatitis C (HCV) will require cell mediated immunity (CMI) as well as neutralising antibody. The vaccine delivery vehicles which are currently in use to generate CMI are not effective because individuals have pre-existing immunity to the delivery vehicle or generate immunity to the vehicle in a multiple dose regimen. This project is designed to overcome this limitation by using multiple vaccine delivery vehicles which encode common HCV proteins.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $497,041.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cell mediated immunity | hepatitis C virus | immune response. | infectious disease | liver | neutralising antibody